Nanexa Ab Stock Five Year Return
| NANEXA Stock | 1.95 0.35 21.87% |
Nanexa AB fundamentals help investors to digest information that contributes to Nanexa AB's financial success or failures. It also enables traders to predict the movement of Nanexa Stock. The fundamental analysis module provides a way to measure Nanexa AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanexa AB stock.
Nanexa |
Nanexa AB Company Five Year Return Analysis
Nanexa AB's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Nanexa AB has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers-Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Nanexa Fundamentals
| Return On Equity | -0.39 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (2.23) % | |||
| Operating Margin | (2.00) % | |||
| Current Valuation | 34.48 M | |||
| Shares Outstanding | 60.7 M | |||
| Shares Owned By Insiders | 40.75 % | |||
| Price To Book | 0.68 X | |||
| Price To Sales | 3.34 X | |||
| Revenue | 2.37 M | |||
| Gross Profit | 4.31 M | |||
| EBITDA | (28.35 M) | |||
| Net Income | (36 M) | |||
| Total Debt | 2.57 M | |||
| Book Value Per Share | 2.19 X | |||
| Cash Flow From Operations | (25.13 M) | |||
| Earnings Per Share | (0.98) X | |||
| Number Of Employees | 19 | |||
| Beta | 0.74 | |||
| Market Capitalization | 244 M | |||
| Total Asset | 165 M | |||
| Z Score | 56.4 | |||
| Net Asset | 165 M |
About Nanexa AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanexa AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanexa AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanexa AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Nanexa Stock
Nanexa AB financial ratios help investors to determine whether Nanexa Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanexa with respect to the benefits of owning Nanexa AB security.